Epic, Zuckerberg, Cellectar, & More: This Week’s Wisconsin Watchlist

(Page 2 of 2)

malignant tumors and certain form of blood cancer, including multiple myeloma. “The data from both of these solid tumor animal studies indicate that multiple doses … resulted in an increased survival benefit over a single dose,” the company said in a press release.

—Madison-based SmartUQ, which is developing software that allows users to test the performance of physical parts and products before manufacturing them on a large scale, raised $1.9 million from 25 individual investors. The startup, which launched in 2014 and counts some of the largest businesses in the U.S. as customers, has now raised more than $4.4 million in outside financing, according to SEC filings.

—A group of neuroscience experts from around the country that includes Justin Williams, a professor of biomedical engineering at the University of Wisconsin-Madison, will receive up to $9.85 million in funding to develop low-cost device that boosts brain activity by stimulating nerves in the user’s head and neck, according to a report by the university’s news service. The funding comes from the Defense Advanced Research Projects Agency, or DARPA, the secretive government organization whose successes include creating an early predecessor to the modern Internet. According to the report, the researchers will design the device with military personnel in mind, but it could also have potential applications for people with Alzheimer’s Disease and other conditions.

Single PageCurrently on Page: 1 2 previous page

Jeff Buchanan is the editor of Xconomy Seattle. Email: jbuchanan@xconomy.com Follow @_jeffbuchanan

Trending on Xconomy